Jeannine Kassis

6.4k total citations · 1 hit paper
64 papers, 2.6k citations indexed

About

Jeannine Kassis is a scholar working on Hematology, Internal Medicine and Surgery. According to data from OpenAlex, Jeannine Kassis has authored 64 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 21 papers in Internal Medicine and 11 papers in Surgery. Recurrent topics in Jeannine Kassis's work include Venous Thromboembolism Diagnosis and Management (21 papers), Acute Myeloid Leukemia Research (13 papers) and Systemic Lupus Erythematosus Research (10 papers). Jeannine Kassis is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (21 papers), Acute Myeloid Leukemia Research (13 papers) and Systemic Lupus Erythematosus Research (10 papers). Jeannine Kassis collaborates with scholars based in Canada, United States and United Kingdom. Jeannine Kassis's co-authors include Susan Solymoss, Susan R. Kahn, Jeffrey S. Ginsberg, Sylvie Desmarais, André Roussin, France Joyal, Ian Shrier, Donna L. Lamping, Mira Johri and Louis Desjardins and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Jeannine Kassis

64 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

2003 544 citations Clive Kearon, Jeffrey S. Ginsberg et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeannine Kassis Canada	25	1.5k	885	868	756	398	64	2.6k
Robert Bona United States	27	1.2k 0.8×	834 0.9×	727 0.8×	937 1.2×	241 0.6×	60	2.4k
Jens Hammerstrøm Norway	22	1.2k 0.8×	429 0.5×	688 0.8×	737 1.0×	161 0.4×	68	2.5k
Gilles Pernod France	27	1.6k 1.0×	678 0.8×	1.4k 1.7×	652 0.9×	182 0.5×	139	2.9k
Rainer Vormittag Austria	20	1.7k 1.1×	336 0.4×	947 1.1×	970 1.3×	455 1.1×	37	2.5k
Tzu‐Fei Wang Canada	22	1.9k 1.3×	463 0.5×	1.5k 1.7×	494 0.7×	552 1.4×	111	2.6k
Daniela Tormene Italy	30	2.9k 1.9×	1.0k 1.1×	1.7k 2.0×	2.3k 3.0×	433 1.1×	82	4.4k
C Janbon France	18	1.8k 1.2×	649 0.7×	1.3k 1.5×	430 0.6×	454 1.1×	46	2.5k
Waldemar E. Wysokiński United States	32	2.1k 1.3×	920 1.0×	1.8k 2.1×	486 0.6×	464 1.2×	168	3.2k
B. Kemkes‐Matthes Germany	23	865 0.6×	830 0.9×	642 0.7×	897 1.2×	91 0.2×	78	2.1k
Sergio Siragusa Italy	26	748 0.5×	360 0.4×	595 0.7×	960 1.3×	144 0.4×	150	2.1k

Countries citing papers authored by Jeannine Kassis

Since Specialization

Citations

This map shows the geographic impact of Jeannine Kassis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeannine Kassis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeannine Kassis more than expected).

Fields of papers citing papers by Jeannine Kassis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeannine Kassis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeannine Kassis. The network helps show where Jeannine Kassis may publish in the future.

Co-authorship network of co-authors of Jeannine Kassis

This figure shows the co-authorship network connecting the top 25 collaborators of Jeannine Kassis. A scholar is included among the top collaborators of Jeannine Kassis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeannine Kassis. Jeannine Kassis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaur, Manraj, Donald M. Arnold, Nancy M. Heddle, et al.. (2021). Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. Blood Advances. 6(3). 785–792. 9 indexed citations

Galanaud, J.‐P., Marc Righini, Aymeric Douillard, et al.. (2020). Long‐term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS‐PTS study. Journal of Thrombosis and Haemostasis. 18(4). 857–864. 22 indexed citations

Chanan‐Khan, Asher, Andrey Zaritskey, Miklós Egyed, et al.. (2017). Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Haematology. 4(11). e534–e543. 29 indexed citations

Fernández, Nicolás, et al.. (2016). Learning-by-Concordance (LbC): introducing undergraduate students to the complexity and uncertainty of clinical practice. Canadian Medical Education Journal. 7(2). e104–113. 30 indexed citations

Easaw, Jacob C., Melissa Shea‐Budgell, Chengliang Wu, et al.. (2015). Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment. Current Oncology. 22(2). 144–144. 38 indexed citations

Easaw, Jacob C., Melissa Shea‐Budgell, Chengliang Wu, et al.. (2015). Canadian Consensus Recommendations on the Management of Venous Thromboembolism in Patients with Cancer. Part 1: Prophylaxis. Current Oncology. 22(2). 133–143. 55 indexed citations

Goldberg, Stuart L., Pierre Fenaux, Michael Craig, et al.. (2014). An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes. Leukemia Research Reports. 3(2). 58–61. 66 indexed citations

Kearon, Clive, Jim A. Julian, Michael J. Kovacs, et al.. (2008). Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood. 112(12). 4432–4436. 81 indexed citations

Sierra, Jorge, Jeff Szer, Jeannine Kassis, et al.. (2008). A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial. BMC Cancer. 8(1). 195–195. 40 indexed citations

10.

Kahn, Susan R., Hadia Shbaklo, Donna L. Lamping, et al.. (2008). Determinants of health‐related quality of life during the 2 years following deep vein thrombosis. Journal of Thrombosis and Haemostasis. 6(7). 1105–1112. 370 indexed citations

11.

Kassis, Jeannine, Carolyn Neville, Joyce Rauch, et al.. (2007). Factors Predictors of Vascular Events with Antiphospholipids Antibodies.. Blood. 110(11). 128–128. 1 indexed citations

12.

Kahn, Susan R., Clive Kearon, J.A. Julian, et al.. (2005). Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis. Journal of Thrombosis and Haemostasis. 3(4). 718–723. 147 indexed citations

13.

Kahn, Susan R., Donna L. Lamping, Thiérry Ducruet, et al.. (2005). Determinants of Health-Related Quality of Life after Deep Venous Thrombosis: Two-Year Results from a Canadian Multicenter Prospective Cohort Study (The VETO Study).. Blood. 106(11). 585–585. 1 indexed citations

14.

Kearon, Clive, Jeffrey S. Ginsberg, Michael J. Kovacs, et al.. (2003). Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism. New England Journal of Medicine. 349(7). 631–639. 544 indexed citations breakdown →

15.

Ligier, Sophie, et al.. (2002). Purpura fulminans and anticardiolipin antibodies in a patient with Grave's disease. Scandinavian Journal of Rheumatology. 31(6). 371–373. 9 indexed citations

16.

Blanc, Richard Le, Robert Bélanger, Lambert Busque, et al.. (2001). Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect. Bone Marrow Transplantation. 28(9). 841–848. 51 indexed citations

17.

Kassis, Jeannine, et al.. (2000). The safe use of epidural anesthesia after subcutaneous injection of low-dose heparin in general abdominal surgery.. PubMed. 43(4). 289–94. 5 indexed citations

18.

Busque, Lambert, et al.. (1997). Familial antiphospholipid syndrome and HLA–DRB gene associations. Arthritis & Rheumatism. 40(10). 1907–1908. 7 indexed citations

19.

Leclerc, Jacques R., William Geerts, Louis Desjardins, et al.. (1996). Prevention of Venous Thromboembolism after Knee Arthroplasty. Annals of Internal Medicine. 25 indexed citations

20.

Bélanger, Robert, Claude Perreault, Y Bonny, et al.. (1993). Allogeneic bone marrow transplantation following busulfan‐cyclophosphamide with or without etoposide conditioning regimen for patients with acute lymphoblastic leukaemia. British Journal of Haematology. 85(4). 706–713. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact